Steering Council

The Steering Council oversees all aspects of the workings of the Network. The terms of reference for the Steering Council are as follows:

Ensure that the Vision and Mission of the SPOR Network are fulfilled through a strategic, accountable, committed leadership and management functions;
Through the skill-based and partnership governance structure, create the highest quality oversight, communication, support and guidance for the conduct of the patient-oriented research goals using best (corporate) governance principles;
Develop appropriate agreement and memorandum documents articulating terms suitable for membership in the SPOR Network including specific description of participation and co-investment of resource (time, expertise, infrastructure and revenues);
Enable strict financial oversight using standard accounting and auditing measures;
Promote strategic partnership relationships with inaugural (core) and new members (academic, public and private) of the SPOR Network with sensitivity to balancing gender, age, language (French, English);
Incorporate local academic and clinical nodes of the Network in strategic project development, implementation and evaluation;
Monitor governance performance including excellence and sustainability of the leadership, management and engagement of the participating members;
Manage conflict of interest through appropriate processes including necessary agreements establish for all aspects of governance and research partnerships.

King, Malcolm (Steering Council Chair)
Scientific Director, Saskatchewan Centre for Patient-Oriented Research

Boileau, Luc
President-Director General
Institut National d’excellence en santé et en services sociaux (INESSS)

Finegood, Diane
Professor
Centre for Dialogue and Semester in Dialogue
Simon Fraser University

Gray, Ross
Patient Representative

Hux, Jan
President and CEO
Diabetes Canada
Patient Representative

Prowten, Dave
President and CEO
JDRF Canada
Patient Representative

Sissmore, Debbie
Patient Representative

Sullivan, Terrence
Chair
Canadian Agency for Drugs & Technologies in Health (CADTH)

Witteman, Holly
Assistant Professor of Medicine
Université Laval
Patient Representative

Baird, Roslynn
Executive Director
Indigenous Diabetes Health Circle

*Additional Members – TBA

Després, Jean-Pierre
Co-Academic Lead, Diabetes Action Canada;
Professor of Kinesiology, Université Laval

Lewis, Gary
Co-Academic Lead, Diabetes Action Canada;
Director, Banting and Best Diabetes Centre (BBDC)
University of Toronto

Whiteside, Catharine
Executive Director, Diabetes Action Canada;
Professor Emerita & Former Dean of Medicine
University of Toronto

Mildred Lim
Business Officer, Diabetes Action Canada

Tracy McQuire
Manager Research Operations, Diabetes Action Canada